title: Comment on Edelman et al. AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes. Diabetes Care 2014;37:2132-2140.
authors.affiliation: Endocrine and Metabolic Consultants, Rockville, MD hrodbard@comcast.net.
authors.forename: Helena W
authors.initials: HW
authors.lastname: Rodbard
authors.affiliation: Novo Nordisk Inc., Princeton, NJ.
authors.forename: Boris
authors.initials: B
authors.lastname: Karolicki
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D061268:Insulin Lispro / Q000008:administration & dosage*; D049528:Insulin, Long-Acting / Q000008:administration & dosage*; D008297:Male
chemical_list: D007004:Hypoglycemic Agents; D061268:Insulin Lispro; D049528:Insulin, Long-Acting